Stelis Biopharma

Stelis Biopharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

Stelis Biopharma is a leading, fully integrated biopharmaceutical contract development and manufacturing organization. The powerhouse to progress your biologic products to market as efficiently as possible, we can cater for the entire product lifecycle for our customers for both drug substances and drug products. Our team has deep expertise in product development and manufacturing with comprehensive capabilities from cell line and process development through to scale up, cGMP manufacturing and fill/finish of proteins and peptides. From our strategic location in Bangalore, India, we leverage the advantages of an emerging technological hub for R&D and next generation manufacturing. Delivering solutions for your most complex biologic projects, we do what it takes to get the job done from our state-of-the-art R&D, scale-up and cGMP manufacturing facilities.

Company Details

Employees
489
Founded
-
Address
Stelis Biopharma Pvt. Ltd. - Research Center, #293,bommasandra Jigani Link Road,jigani Industrial Area,anekal,australia
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
stelis.com
HQ
Bangalore, Karnataka
Looking for a particular Stelis Biopharma employee's phone or email?

Stelis Biopharma Questions

News

Stelis BioSource® - Pharmaceutical Technology

Stelis BioSource® Pharmaceutical Technology

Syngene adding biologics capacity through $86m Stelis plant - BioProcess International

Syngene adding biologics capacity through $86m Stelis plant BioProcess International

Syngene Acquires Multi-Modal Facility from Stelis Biopharma - Contract Pharma

Syngene Acquires Multi-Modal Facility from Stelis Biopharma Contract Pharma

Stelis, Strides and Steriscience merge to form new CDMO - Pharmafile

Stelis, Strides and Steriscience merge to form new CDMO Pharmafile

Stelis Biopharma’s two biologics manufacturing facilities receive EU cGMP accreditation - Indian Pharma Post

Stelis Biopharma’s two biologics manufacturing facilities receive EU cGMP accreditation Indian Pharma Post

RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine - Sputnik V

RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine Sputnik V

Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd - ET HealthWorld

Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd ET HealthWorld

Strides Pharma To Spin Off Contract Manufacturing Unit Into Stelis Biopharma - NDTV Profit

Strides Pharma To Spin Off Contract Manufacturing Unit Into Stelis Biopharma NDTV Profit

Stelis' Biologics Manufacturing Facility Expansion, Bangalore, India - Pharmaceutical Technology

Stelis' Biologics Manufacturing Facility Expansion, Bangalore, India Pharmaceutical Technology

Stelis Biopharma appoints Mark W Womack as CEO - BioSpectrum India

Stelis Biopharma appoints Mark W Womack as CEO BioSpectrum India

Stelis concludes US$ 195m Series B and Series C fund raise - Healthcare Radius

Stelis concludes US$ 195m Series B and Series C fund raise Healthcare Radius

Stelis Biopharma receives EIR from the US FDA for Drug-Device Combination Products - Moneycontrol

Stelis Biopharma receives EIR from the US FDA for Drug-Device Combination Products Moneycontrol

(PDF) The Cuckoo Bees of the Genus Stelis Panzer, 1806 in Europe, North Africa and the Middle East - researchgate.net

(PDF) The Cuckoo Bees of the Genus Stelis Panzer, 1806 in Europe, North Africa and the Middle East researchgate.net

To be, or not to be a Stelis - scielo.sa.cr

To be, or not to be a Stelis scielo.sa.cr

CDMO Stelis Continues Expansion - Contract Pharma

CDMO Stelis Continues Expansion Contract Pharma

Stelis Biopharma updates on receipt of consideration from Syngene - Indian Pharma Post

Stelis Biopharma updates on receipt of consideration from Syngene Indian Pharma Post

Stelis Biopharma appoints Mark W. Womack as CEO - ETHRWorld.com

Stelis Biopharma appoints Mark W. Womack as CEO ETHRWorld.com

A new Stelis (Orchidaceae: Pleurothallidinae) from the Western Andes of Colombia - scielo.sa.cr

A new Stelis (Orchidaceae: Pleurothallidinae) from the Western Andes of Colombia scielo.sa.cr

Stelis Biopharma’s flagship facility receives EIR from USFDA - Indian Pharma Post

Stelis Biopharma’s flagship facility receives EIR from USFDA Indian Pharma Post

Stelis Biopharma receives EU-GMP compliance certificate for two manufacturing facilities - ET HealthWorld

Stelis Biopharma receives EU-GMP compliance certificate for two manufacturing facilities ET HealthWorld

Strides Pharma says biotech associate Stelis in talks with global vaccine cos for manufacturing deal - Moneycontrol

Strides Pharma says biotech associate Stelis in talks with global vaccine cos for manufacturing deal Moneycontrol

Strides Pharma board approves addnl USD 40 mn investment in Stelis Biopharma - The Economic Times

Strides Pharma board approves addnl USD 40 mn investment in Stelis Biopharma The Economic Times

Unable to sell Sputnik Light stock, Stelis Biopharma requests PM Modi for procurement of jabs - The Economic Times

Unable to sell Sputnik Light stock, Stelis Biopharma requests PM Modi for procurement of jabs The Economic Times

Syngene buys biologics manufacturing unit from Stelis Biopharma - Healthcare Radius

Syngene buys biologics manufacturing unit from Stelis Biopharma Healthcare Radius

Mr Loganathan S, AVP (Device Development & Packaging), Stelis Biopharma - Express Pharma

Mr Loganathan S, AVP (Device Development & Packaging), Stelis Biopharma Express Pharma

Stelis Biopharma’s facility receives EIR from USFDA - Express Pharma

Stelis Biopharma’s facility receives EIR from USFDA Express Pharma

Upgrading acquired Stelis unit to triple Syngene's biologics capacity by H2 - Business Standard

Upgrading acquired Stelis unit to triple Syngene's biologics capacity by H2 Business Standard

Stelis sells Bengaluru facility to Biocon arm Syngene for Rs 702 cr - Business Standard

Stelis sells Bengaluru facility to Biocon arm Syngene for Rs 702 cr Business Standard

Strides Pharma to demerge biotech business under Stelis Biopharma - Medical Dialogues

Strides Pharma to demerge biotech business under Stelis Biopharma Medical Dialogues

Syngene concludes acquisition of biologics facility from Stelis Biopharma - Express Pharma

Syngene concludes acquisition of biologics facility from Stelis Biopharma Express Pharma

Stelis Biopharma appoints Raghavendra Rao as new CHRO - HR Katha

Stelis Biopharma appoints Raghavendra Rao as new CHRO HR Katha

Syngene to acquire plant from Stelis Biopharma for Rs 702 crore - Moneycontrol

Syngene to acquire plant from Stelis Biopharma for Rs 702 crore Moneycontrol

Strides re-enters injectable biz, to take controlling stake in Stelis Biopharma - Moneycontrol

Strides re-enters injectable biz, to take controlling stake in Stelis Biopharma Moneycontrol

Stelis CEO steps down after Indian firm signs deal for Russia vaccine - Business Standard

Stelis CEO steps down after Indian firm signs deal for Russia vaccine Business Standard

Strides' board approves demerger of biotech business under Stelis Biopharma - Moneycontrol

Strides' board approves demerger of biotech business under Stelis Biopharma Moneycontrol

Bengaluru-based Stelis Biopharma to make 200 million doses of Sputnik V Covid vaccine - The Indian Express

Bengaluru-based Stelis Biopharma to make 200 million doses of Sputnik V Covid vaccine The Indian Express

Syngene acquires facility from Stelis Biopharma for ₹ 702 cr - The Hindu

Syngene acquires facility from Stelis Biopharma for ₹ 702 cr The Hindu

Aditya Puri joins Strides Group as Advisor and Stelis Biopharma as Director - Healthcare Radius

Aditya Puri joins Strides Group as Advisor and Stelis Biopharma as Director Healthcare Radius

HDFC founder, Aditya Puri joins Strides Group as Advisor and Director of Stelis Biopharma - Express Pharma

HDFC founder, Aditya Puri joins Strides Group as Advisor and Director of Stelis Biopharma Express Pharma

Top Stelis Biopharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant